Attributes | Values |
---|
rdf:type
| |
Description
| - Synthesis, crystal structures and biological activities for the new chlorobridged mixed valence CuI/CuII coordination polymer [CuIIcyclam][CuICl3] 1 and [H4cyclam][Cu2 I Cl6] 2 are reported. Compound 1 crystallizes in the orthorhombic system, space group Pccn. Its crystal structure consists of one-dimensional polymer CuIIcyclam–Cl–CuI–Cl–CuIIcyclam. Compound 2 is monoclinic (P21/n)with the tetraprotonated cyclam H4cyclam(4+) in (3,4,3,4)-B conformation. Compound 1 was tested to understand its influence on enzyme activity, immunomodulation as well as its toxicity and antiglycation potential. Its effect was significant as immunomodulatory and inhibitory activity against b-glucuronidase enzyme.
- Synthesis, crystal structures and biological activities for the new chlorobridged mixed valence CuI/CuII coordination polymer [CuIIcyclam][CuICl3] 1 and [H4cyclam][Cu2 I Cl6] 2 are reported. Compound 1 crystallizes in the orthorhombic system, space group Pccn. Its crystal structure consists of one-dimensional polymer CuIIcyclam–Cl–CuI–Cl–CuIIcyclam. Compound 2 is monoclinic (P21/n)with the tetraprotonated cyclam H4cyclam(4+) in (3,4,3,4)-B conformation. Compound 1 was tested to understand its influence on enzyme activity, immunomodulation as well as its toxicity and antiglycation potential. Its effect was significant as immunomodulatory and inhibitory activity against b-glucuronidase enzyme. (en)
|
Title
| - Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies
- Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies (en)
|
skos:prefLabel
| - Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies
- Two new halocuprates complexes [CuII(1,4,8,11-tetraazacyclotetradecane)][CuI Cl3] and [H4(1,4,8,11-tetrazacyclotetradecane)][CuI 2Cl6]: synthesis, characterizations and biological studies (en)
|
skos:notation
| - RIV/68378271:_____/12:00388275!RIV13-AV0-68378271
|
http://linked.open...avai/predkladatel
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68378271:_____/12:00388275
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - mixed valence; copper(I/II) complexes; halocuprates; tetraazacyclotetradecane; x-ray structures; beta-glucuronidase; enzyme inhibition (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Medicinal Chemistry Research
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Dušek, Michal
- Fejfarová, Karla
- El Bali, B.
- Lachkar, M.
- Bezgour, A.
- Halime, I.
- Choudhary, M. I.
- Khan, A.
- Marasini, B. P.
- Noreen, S.
- Rasheed, S.
- Siddiq, S.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1007/s00044-011-9968-7
|
is http://linked.open...avai/riv/vysledek
of | |